A science guy from the deep south (Destin) and a humanities guy from the wild west (Matt Whitman) discuss deep questions with varying levels of maturity.
…
continue reading
Content provided by Jayanth Sridhar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jayanth Sridhar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
MP3•Episode home
Manage episode 228806104 series 1302113
Content provided by Jayanth Sridhar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jayanth Sridhar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. Ajay Kuriyan from University of Rochester and Dr. Shriji Patel from Vanderbilt University the show for a journal club focusing on 3 recent publications in major ophthalmology journals, including a prospective study examining ranibizumab and aflibercept for wet macular degeneration, a sub analysis examining factors associated with better anatomic and visual improvements in Protocol T, and paper detailing the natural history of central serous retinopathy. IVR versus IVA for wet AMD (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2722672) Protocol T subanalysis (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2722673) CSR natural history (https://www.aaojournal.org/article/S0161-6420(17)32067-5/fulltext) Financial Disclosures: Dr. Kuriyan is a consultant for Regeneron, Allergan, Alimera, and Valeant and receives grant funding from Second Sight. Dr. Patel has no disclosures. Dr. Sridhar is a consultant for Allergan, Alimera Science, and Alcon Laboratories.
…
continue reading
332 episodes
MP3•Episode home
Manage episode 228806104 series 1302113
Content provided by Jayanth Sridhar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jayanth Sridhar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. Ajay Kuriyan from University of Rochester and Dr. Shriji Patel from Vanderbilt University the show for a journal club focusing on 3 recent publications in major ophthalmology journals, including a prospective study examining ranibizumab and aflibercept for wet macular degeneration, a sub analysis examining factors associated with better anatomic and visual improvements in Protocol T, and paper detailing the natural history of central serous retinopathy. IVR versus IVA for wet AMD (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2722672) Protocol T subanalysis (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2722673) CSR natural history (https://www.aaojournal.org/article/S0161-6420(17)32067-5/fulltext) Financial Disclosures: Dr. Kuriyan is a consultant for Regeneron, Allergan, Alimera, and Valeant and receives grant funding from Second Sight. Dr. Patel has no disclosures. Dr. Sridhar is a consultant for Allergan, Alimera Science, and Alcon Laboratories.
…
continue reading
332 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.